Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC
- Status
- TERMINATED
- Phase
- PHASE1
Safety Study to Evaluate BMS-830216 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
- Status
- COMPLETED
- Phase
- PHASE3
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Living Well With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- NA
Strategic Timing of Antiretroviral Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE4
Study of Immunotherapy to Treat Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
First Line Hepato Cellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE3
Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
- Status
- TERMINATED
- Phase
- PHASE2
Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2